Subtopic Deep Dive
HIV Mother-to-Child Transmission
Research Guide
What is HIV Mother-to-Child Transmission?
HIV mother-to-child transmission refers to vertical HIV transfer from infected mothers to infants during pregnancy, labor, delivery, or breastfeeding, preventable by antiretroviral interventions like zidovudine and nevirapine.
Interventions such as single-dose nevirapine and zidovudine regimens reduced transmission rates in trials like HIVNET 012 (Guay et al., 1999, 1645 citations). Resource-limited settings prioritize affordable prophylaxis, as outlined in De Cock et al. (2000, 1089 citations). Over 50 papers in the provided list address prophylaxis efficacy and guidelines.
Why It Matters
Antiretroviral prophylaxis cut mother-to-child transmission from 25-30% to under 5% in high-burden areas, enabling pediatric HIV elimination goals (De Cock et al., 2000). Trials like HIVNET 012 showed nevirapine superiority over zidovudine in Uganda, influencing WHO policies (Guay et al., 1999). Early therapy integration protects 590,000 infants annually in resource-poor countries, reducing sub-Saharan Africa's HIV burden (Kharsany and Abdool Karim, 2016).
Key Research Challenges
Resource-Limited Prophylaxis Access
Implementing zidovudine or nevirapine in sub-Saharan Africa faces infrastructure barriers (De Cock et al., 2000). High costs and supply chain issues limit coverage despite proven efficacy (Kharsany and Abdool Karim, 2016). Scaling single-dose regimens requires sustained funding.
Breastfeeding Transmission Risks
Postnatal HIV transmission via breastfeeding persists despite maternal ART (Guay et al., 1999). Balancing nutrition needs with prophylaxis in low-resource settings challenges elimination (De Cock et al., 2000). Optimal regimens need further trials.
Neonatal Outcome Monitoring
Long-term effects of prophylaxis like nevirapine on infant development remain understudied (Guay et al., 1999). Viral resistance risks from single-dose therapies require surveillance (Cohen et al., 2011). Global strategies demand standardized outcome metrics.
Essential Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
Myron S. Cohen, Ying Qing Chen, Marybeth McCauley et al. · 2011 · New England Journal of Medicine · 6.9K citations
The early initiation of antiretroviral therapy reduced rates of sexual transmission of HIV-1 and clinical events, indicating both personal and public health benefits from such therapy. (Funded by t...
Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents
· 1998 · Annals of Internal Medicine · 5.2K citations
Principles of Therapy of HIV Infection and Guidelines for the Use of Antiretroviral Agents in HIV-Infected PersonsJune 15, 1998Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults...
Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men
Robert M. Grant, Javier R. Lama, Peter L. Anderson et al. · 2010 · New England Journal of Medicine · 5.0K citations
Oral FTC-TDF provided protection against the acquisition of HIV infection among the subjects. Detectable blood levels strongly correlated with the prophylactic effect. (Funded by the National Insti...
Antiretroviral Preexposure Prophylaxis for Heterosexual HIV Transmission in Botswana
Michael C. Thigpen, Poloko Kebaabetswe, Lynn Paxton et al. · 2012 · New England Journal of Medicine · 2.0K citations
Daily TDF-FTC prophylaxis prevented HIV infection in sexually active heterosexual adults. The long-term safety of daily TDF-FTC prophylaxis, including the effect on bone mineral density, remains un...
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
Laura Guay, Philippa Musoke, Thomas R. Fleming et al. · 1999 · The Lancet · 1.6K citations
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa
The TEMPRANO ANRS 12136 Study Group · 2015 · New England Journal of Medicine · 1.2K citations
In this African country, immediate ART and 6 months of IPT independently led to lower rates of severe illness than did deferred ART and no IPT, both overall and among patients with CD4+ counts of a...
British HIV Association guidelines for the treatment of HIV‐1‐infected adults with antiretroviral therapy 2008
B G Gazzard, on behalf of the BHIVA Treatment Guidelines Writing Group · 2008 · HIV Medicine · 1.1K citations
Table of contents 1.0 Introduction 2.0 Methodology 2.1 Basing recommendations on evidence 2.2 Implications for research 2.3 Use of surrogate marker data 2.4 Issues concerning design and analysis of...
Reading Guide
Foundational Papers
Start with Guay et al. (1999, HIVNET 012, 1645 citations) for nevirapine vs. zidovudine trial; then De Cock et al. (2000, 1089 citations) for resource-poor strategies; Cohen et al. (2011, 6875 citations) links to early ART benefits.
Recent Advances
Kharsany and Abdool Karim (2016) updates sub-Saharan challenges; TEMPRANO (2015) shows immediate ART impacts; Thigpen et al. (2012) informs prophylaxis safety.
Core Methods
Randomized trials (HIVNET 012), cohort prophylaxis studies, guideline syntheses (Gazzard, 2008), and epidemiological modeling assess transmission rates and interventions.
How PapersFlow Helps You Research HIV Mother-to-Child Transmission
Discover & Search
Research Agent uses searchPapers and exaSearch to find trials like 'Intrapartum and neonatal single-dose nevirapine compared with zidovudine' (Guay et al., 1999), then citationGraph reveals 1645 citing works on vertical transmission prophylaxis. findSimilarPapers expands to resource-poor interventions from De Cock et al. (2000).
Analyze & Verify
Analysis Agent applies readPaperContent to extract HIVNET 012 trial data (Guay et al., 1999), verifies transmission rates with verifyResponse (CoVe), and runs PythonAnalysis for meta-analysis of prophylaxis efficacy using pandas on citation metrics. GRADE grading assesses evidence quality for nevirapine vs. zidovudine.
Synthesize & Write
Synthesis Agent detects gaps in breastfeeding prophylaxis post-Guay et al. (1999), flags contradictions with Cohen et al. (2011) early ART data. Writing Agent uses latexEditText, latexSyncCitations for guideline drafts, and latexCompile for PMTCT review papers with exportMermaid timelines of intervention evolution.
Use Cases
"Compare nevirapine vs zidovudine transmission rates in African trials with statistical analysis"
Research Agent → searchPapers('HIVNET 012') → Analysis Agent → readPaperContent + runPythonAnalysis (pandas t-test on rates from Guay et al., 1999 and De Cock et al., 2000) → researcher gets p-values and forest plot CSV.
"Draft LaTeX review on PMTCT guidelines evolution"
Synthesis Agent → gap detection on guidelines (Gazzard, 2008) → Writing Agent → latexEditText + latexSyncCitations (Guay et al., 1999; Cohen et al., 2011) + latexCompile → researcher gets compiled PDF with citations and figures.
"Find code for modeling mother-to-child HIV transmission risks"
Research Agent → searchPapers('PMTCT modeling') → Code Discovery → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → researcher gets R/Python scripts simulating prophylaxis efficacy from De Cock et al. (2000)-inspired models.
Automated Workflows
Deep Research workflow conducts systematic review of 50+ PMTCT papers via searchPapers → citationGraph → GRADE grading, producing structured reports on nevirapine efficacy (Guay et al., 1999). DeepScan applies 7-step analysis with CoVe checkpoints to verify De Cock et al. (2000) resource challenges. Theorizer generates hypotheses on ART integration from Cohen et al. (2011) and Kharsany (2016).
Frequently Asked Questions
What is HIV mother-to-child transmission?
Vertical HIV transmission occurs during pregnancy, delivery, or breastfeeding without intervention, reduced to <5% with antiretrovirals like zidovudine (De Cock et al., 2000).
What are key prevention methods?
Single-dose nevirapine outperformed zidovudine in HIVNET 012 trial (Guay et al., 1999, 1645 citations); combination prophylaxis is standard in guidelines (Gazzard, 2008).
What are seminal papers?
HIVNET 012 (Guay et al., 1999) and 'Prevention in Resource-Poor Countries' (De Cock et al., 2000, 1089 citations) established nevirapine and scalable interventions.
What open problems remain?
Breastfeeding transmission under ART, resistance monitoring, and long-term neonatal effects lack resolution (Kharsany and Abdool Karim, 2016; Guay et al., 1999).
Research HIV/AIDS Research and Interventions with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching HIV Mother-to-Child Transmission with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers